Addiction News and Research RSS Feed - Addiction News and Research

Opioid withdrawal in Ontario newborns increases 15-fold

Opioid withdrawal in Ontario newborns increases 15-fold

The number of newborns suffering from opioid withdrawal increased 15-fold in Ontario over 20 years, according to research published today in CMAJ Open. [More]
UC San Diego School of Medicine project receives 2015 Avant-Garde Award for HIV/AIDS Research

UC San Diego School of Medicine project receives 2015 Avant-Garde Award for HIV/AIDS Research

A University of California, San Diego School of Medicine project involving the creation of miniature models of the human brain - developed with stem cells - to study neurological disorders caused by HIV and methamphetamine use has been named one of five recipients of the 2015 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse. [More]
Plain tobacco packaging less effective at prompting smokers to light up

Plain tobacco packaging less effective at prompting smokers to light up

Plain tobacco packaging may reduce the likelihood of smokers seeking to obtain cigarettes by almost 10% compared to branded packs, according to research from the Universities of Exeter and Bristol. [More]
Five researchers selected to receive 2015 Avant-Garde Award for HIV/AIDS Research

Five researchers selected to receive 2015 Avant-Garde Award for HIV/AIDS Research

With proposals ranging from innovative therapies to the development of unique organoid models of the brain, five scientists have been selected to receive the 2015 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse, part of the National Institutes of Health. The five scientists will each receive $500,000 per year for five years to support their research. [More]
FDA accepts NDA filing for Inspirion Delivery Technologies' investigational drug, MorphaBond ER

FDA accepts NDA filing for Inspirion Delivery Technologies' investigational drug, MorphaBond ER

Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine. [More]
Study explores effects of medical marijuana in children and teens with ASD, ADHD

Study explores effects of medical marijuana in children and teens with ASD, ADHD

As medical marijuana becomes increasingly accepted, there is growing interest in its use for children and adolescents with developmental and behavioral problems such as autism spectrum disorders (ASD) and attention-deficit/hyperactivity disorder (ADHD), according to a review in the February Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics. [More]
Medicare coverage of CT lung cancer screening can save more lives

Medicare coverage of CT lung cancer screening can save more lives

Medicare's final decision to cover computed tomography (CT) lung cancer screening gives seniors at high-risk for the disease access to care that can save more lives than any cancer screening test in history. [More]
Electronic cigarettes and smoking cessation: an interview with Professor Peter Hajek

Electronic cigarettes and smoking cessation: an interview with Professor Peter Hajek

The electronic cigarette has been invented by Chinese pharmacist Hon Lik in 2003. The rise in electronic cigarettes (EC) popularity was initially a grass root phenomenon. EC are estimated to be at least 95% safer than cigarettes and they appeal to smokers who cannot or do not want to stop smoking, but who want to reduce the risks smoking poses to their health. [More]
Policymakers need to look beyond painkiller abuse to reduce opioid overdose deaths, say researchers

Policymakers need to look beyond painkiller abuse to reduce opioid overdose deaths, say researchers

According to researchers at Brandeis University, the University of North Florida and Johns Hopkins University, policymakers must look beyond painkiller abuse, also called non-medical use, in their efforts to reduce opioid overdose deaths. [More]
Study could lead to potential drug treatment for fighting addiction

Study could lead to potential drug treatment for fighting addiction

A research team led by the University of Colorado Boulder has discovered a mechanism in the brain that is key to making cocaine seem pleasurable, a finding that could lead to a drug treatment for fighting addiction. [More]
Researchers identify a common pattern across different psychiatric disorders

Researchers identify a common pattern across different psychiatric disorders

In a study analyzing whole-brain images from nearly 16,000 people, researchers at the Stanford University School of Medicine identified a common pattern across a spectrum of psychiatric disorders that are widely perceived to be quite distinct. [More]
Study findings could offer roadmap for preventing deaths from drug overdoses

Study findings could offer roadmap for preventing deaths from drug overdoses

Results from a new study show that participants in drug overdose education programs tend to be parents (mostly mothers) who provide financial support for their son/daughter, have daily contact with their loved one, have applied for court-mandated treatment and have witnessed an overdose. [More]
Altered dopamine signaling may contribute to autism

Altered dopamine signaling may contribute to autism

Newly discovered genetic variations linked to autism spectrum disorder (ASD) disrupt the function of the dopamine transporter, suggesting that altered dopamine signaling contributes to this common developmental condition, according to a Vanderbilt University-led research team. [More]
Rogers' regional medical director to address issue of childhood anxiety at NATSAP conference

Rogers' regional medical director to address issue of childhood anxiety at NATSAP conference

Stephanie C. Eken, M.D., F.A.A.P., a regional medical director with Rogers Behavioral Health System, will address the issue of childhood anxiety at the 2015 National Association of Therapeutic Schools and Programs (NATSAP) conference on February 6 in Nashville, TN. [More]
Brain inflammation linked to clinical depression

Brain inflammation linked to clinical depression

A new study by the Centre for Addiction and Mental Health found that the measure of brain inflammation in people who were experiencing clinical depression was increased by 30 per cent. The findings, published today in JAMA Psychiatry, have important implications for developing new treatments for depression. [More]
Researchers advance generalized concept for future studies of mental resilience

Researchers advance generalized concept for future studies of mental resilience

Researchers at the Research Center Translational Neurosciences of Johannes Gutenberg University Mainz in Germany have advanced a generalized concept as the basis for future studies of mental resilience. Their new approach is based on a mechanistic theory which takes as its starting point the appraisals made by the brain in response to exposure to stressful or threatening situations. [More]
Ghrelin hormone supplement increases sexual activity in mice

Ghrelin hormone supplement increases sexual activity in mice

Swedish studies show that mice that receive a supplement of the "appetite hormone" ghrelin increase their sexual activity. Whether the hormone has the same impact on humans is unknown - but if it does, the researchers may have found the key to future treatments for sex abuse. [More]
Kaleo, CHMI partner to reduce prescription drug-related deaths

Kaleo, CHMI partner to reduce prescription drug-related deaths

Kaleo, a privately-held pharmaceutical company, today announced a national strategic partnership with the Clinton Health Matters Initiative, an initiative of the Clinton Foundation, that will help support its goal of cutting prescription drug-related deaths in half, saving approximately 10,000 lives over five years. [More]
Alcohol drinking pattern influences risk of cirrhosis

Alcohol drinking pattern influences risk of cirrhosis

Approximately 170,000 people die from alcoholic cirrhosis of the liver in Europe every year. Although alcohol is the most important risk factor, less is known about the significance of different patterns of drinking. Currently scientists believe that cirrhosis is a function of the volume of alcohol consumed irrespective of patterns of drinking. Investigators have now established that alcohol drinking pattern has a significant influence on the risk of cirrhosis and that daily drinking increases that risk compared with drinking less frequently. [More]

Study: Classic psychedelics may hold great promise in preventing suicide

Classic psychedelics, such as LSD, psilocybin mushrooms and mescaline, previously have been shown to occasion lasting improvements in mental health. But researchers led by University of Alabama at Birmingham School of Public Health investigators wanted to advance the existing research and determine whether classic psychedelics might be protective with regard to suicidal thoughts. [More]